Post Traumatic Stress Disorder News and Research

RSS

Is the microbiome linked to post-traumatic stress disorder outcomes?

The potential role of the microbiome-gut-brain axis in this interaction.

21 Nov 2023

Exploring the use of psychedelics as novel treatments for psychiatric disorders

Psychedelic compounds such as psilocybin, a substance found in various mushroom species, are garnering more research support as novel treatments for psychiatric disorders, but questions remain concerning who they may help the most.

13 Nov 2023

Study finds significant associations between sex work and muscle dysmorphia

Using data from over 900 participants in a large, diverse, and national sample of Canadian adolescents and young adults from the Canadian Study of Adolescent Health Behaviors, a new study published in the journal Sexual Health researchers found significant associations between sex work and muscle dysmorphia.

10 Nov 2023

How do sex hormones and birth control affect brain fear circuits?

Researchers explores how oral contraceptive pill use interacts with the current hormonal status to affect the fear circuit structure within the brain.

9 Nov 2023

Life's hardships rewire the brain: Study pinpoints neural changes from adversity

Research reveals that adverse life experiences heighten amygdala response and diminish prefrontal cortex activity, indicating potential neural mechanisms of psychological vulnerability.

5 Nov 2023

Clinical trial launched to explore new drug treatments for military personnel and veterans with PTSD

A groundbreaking clinical trial launched October 16 will explore the promise of new drug treatments for military personnel and veterans suffering from post-traumatic stress disorder (PTSD).

26 Oct 2023

California expands paid sick days and boosts health worker wages

California continues to burnish its reputation as a progressive state for health policy as Gov. Gavin Newsom signed bills expanding paid sick leave, adding bereavement leave for miscarriages, and boosting wages for health workers.

25 Oct 2023

Clinical study evaluates safety and efficacy of methylone in patients with severe PTSD

Clerkenwell Health, the modern mental health company specializing in matching patients with cutting-edge psychiatry treatments, today announced that it is taking part in Transcend Therapeutics’ Phase 2 study evaluating the safety and efficacy of methylone in patients with severe PTSD.

20 Oct 2023

New study investigates the relationship between PTSD, diet, and the gut microbiome

The human gut microbiome has a significant impact on our health. Research has shown that it can influence the development and response of emotions, but the relationship between post-traumatic stress disorder (PTSD) and the gut microbiome has been unexplored.

19 Oct 2023

Daylight heals, night light steals: The surprising link between light exposure and mental health

Researchers find that increased night-time light exposure is linked to higher risks of various psychiatric disorders including depression and anxiety, while more daylight exposure lowers these risks. The large-scale study suggests modulating light patterns could be a non-pharmacological strategy for improving mental health.

12 Oct 2023

Psychedelic therapy shows promise for treating veterans with PTSD and brain injury

One treatment each of two psychedelic drugs lowered depression and anxiety and improved cognitive functioning in a sample of U.S. special operations forces veterans who sought care at a clinic in Mexico, according to a new analysis of the participants' charts.

5 Oct 2023

Study shows consanguinity may raise risk of type 2 diabetes and other common diseases

A new study finds that consanguinity – unions between close relatives – may increase the risk of common diseases such as type 2 diabetes and post-traumatic stress disorder (PTSD).

30 Sep 2023

New research uncovers autozygosity's impact on common disease risks

Researchers explored the associations between autozygosity, measured as the fraction of the genome in runs of homozygosity (FROH), and common diseases, focusing on populations with high consanguinity rates.

29 Sep 2023

Artificial intelligence models for diagnosing post-traumatic stress disorder

Whether AI may be a promising strategy for post-traumatic stress disorder (PTSD) diagnosis.

29 Sep 2023

Greater PTSD symptoms lead to worse sexual functioning among midlife women

Post-traumatic stress disorder (PTSD) has been associated with a number of adverse mental and physical health outcomes. Little is known, however, regarding its impact on sexual functioning among midlife women.

27 Sep 2023

Unions between close relatives may increase the risk of common diseases, study finds

A new study finds that consanguinity – unions between close relatives - may increase the risk of common diseases such as type 2 diabetes and post-traumatic stress disorder (PTSD).

26 Sep 2023

Can training to suppress thoughts improve mental health? Study challenges century-old wisdom

Researchers describe the effects of thought suppression on mnemonic, affective, positive, or negative mental health indices.

26 Sep 2023

Think again: Suppressing negative thoughts may actually improve mental health

Suppressing negative thoughts may not be harmful after all, says new study from University of Cambridge researchers. Training participants to actively suppress worrisome thoughts led to less vivid fears and improved mental health, challenging the notion that thought suppression is maladaptive.

21 Sep 2023

New brain biomarker predicts recovery from treatment-resistant depression

Using a novel deep brain stimulation (DBS) device capable of recording brain signals, researchers have identified a pattern of brain activity or "biomarker" related to clinical signs of recovery from treatment-resistant depression.

20 Sep 2023

Transforming postpartum depression treatment with neurosteroids

A new study in Neuropsychopharmacology delves into the mechanisms of action of brexanolone, the first FDA-approved, rapid-acting antidepressant specifically for postpartum depression (PPD). The research highlights brexanolone's potential anti-inflammatory effects and its impact on GABAA receptors, offering insights into its efficacy and suggesting avenues for further study.

19 Sep 2023